What are biosynthetic cannabinoids? And what do they mean for pharma?

Neil Mahapatra gives the story behind a partnership with Oxford University to develop cannabinoid medicines

How unravelling the complex chemistry of the cannabis plant can lead to new medicines

Roger Pertwee discusses his pioneering work into cannabis, cannabinoids and the endocannabinoid system

What's causing pharma's fascination with cannabinoids and cannabis?

Sitting Down With Elisa Cascade, President of Data Solutions at DrugDev

Data management is a key factor for success with serialization

Drug costs could be lowered if review and approval processes were much faster

Sharing data about dangerous chemical reactions could boost laboratory safety

Free cancer drugs, mispackaged contraceptive pills, and antibiotic action… What's new for pharma in business?